Home » Topics » BioWorld Science

BioWorld Science
RSS

New NFE2L2 activators identified at GlaxoSmithKline

July 11, 2018

Positive phase I results announced for Vivus' VI-0106

July 11, 2018

miRagen launches phase II study of MRG-201

July 11, 2018

Initiation of phase II clinical trial of BPN-14770 in fragile X syndrome

July 11, 2018

New abzymes presented for diagnosing multiple sclerosis

July 11, 2018

Renal anemia treatment: new oral HIF prolyl hydroxylase inhibitor promotes EPO production in rodents

July 11, 2018

APC11 has prognostic significance in colorectal cancer

July 11, 2018

Aeromics initiates phase I study of AER-271 in healthy volunteers

July 11, 2018

New rat model of diabetic cardiopathy described

July 11, 2018

Researchers find novel mutation in CLCC1 gene tied to retinitis pigmentosa

July 11, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...